Led · Equity · Jul 2026

Founded in 2014 and headquartered in Louvain-la-Neuve, e-peas develops and markets ultra-low-power semiconductor technology that enables devices to operate from ambient energy sources such as light, RF, vibration, and heat. Its product portfolio includes energy-harvesting power management ICs, microcontrollers, and sensor solutions backed by about 15 years of research and patented IP. The company says its solutions power high-volume applications including solar-powered remote controls, HVAC systems, cameras, and smart tracking devices for global customers. e-peas aims to extend battery lifespans and eliminate battery replacements for industrial and IoT device designers. Financially, the company has raised multiple rounds including €8 million in 2020, €17.5 million in March 2024, and the recent €19.2 million round to support commercial scaling and international expansion. The firm also maintains offices in Switzerland and the USA.

Led · Series B · Mar 2026

Standing Ovation develops a patented precision fermentation process that upcycles whey permeates and agricultural sugars into high-quality casein proteins used across the agrifood industry. The company has protected its technology with eight patent families and positions its approach as a circular alternative to traditional animal casein. An ISO-certified life cycle assessment cited by the company indicates a 74% reduction in greenhouse gas emissions and up to three times less water use versus animal casein. By repurposing dairy side-streams that were previously low-value, Standing Ovation aims to create new revenue streams for producers and reduce reliance on international supply chains. The company has attracted institutional and strategic investors including Astanor, Bel Group, Seventure Partners, Big Idea Ventures and Danone Ventures. With the recent Series B and accompanying non-dilutive financing, Standing Ovation is funding commercial rollout in the U.S. and planned expansion into Europe and Asia starting at the end of 2027.

Participated · Debt Financing · Nov 2025

Founded by Mohamed Gastli and Syrine Chaalala, Paris- and Tunis-based nextProtein upcycles low-value agricultural and food byproducts into three core offerings: nextMeal protein powder, nextOil insect oil, and nextGrow organic fertilizer. The company relies on Black Soldier Fly larvae and a rigorously optimized feedstock recipe—tested across more than 100 ingredients—to achieve competitive feed conversion ratios while keeping CAPEX and OPEX low. Its products aim to replace resource-intensive commodities such as fishmeal and soy, offering a circular, lower-carbon alternative for global animal-feed supply chains. Proceeds from its latest raise will finance construction of a second, large-scale facility in Tunisia that is designed to output 12,000 tons of insect-based ingredients annually, including 2,500 tons of protein powder. Management believes achieving industrial scale and cost parity will move insect protein from niche to mainstream adoption. The company’s capital-efficient model and continuous R&D give it confidence to compete on both cost and reliability with traditional feed ingredients.

Led · Equity · Oct 2025

Founded in 2021, EverDye designs a textile-dyeing technology that works at lower temperatures using existing factory equipment, drastically reducing water consumption and greenhouse-gas emissions compared with conventional methods. The company positions its process as both an environmental and cost-saving solution for manufacturers facing rising energy prices. By eliminating the need for complex new industrial installations, EverDye claims to lower operating costs while helping brands meet sustainability targets. Its technology targets a fashion sector responsible for roughly 8 % of global emissions and significant water pollution. EverDye’s management, led by CEO Philippe Berlan, emphasizes that sustainability can be a competitive advantage in the dyeing supply chain. The startup has attracted investor backing to commercialize and scale its platform, most recently raising €15 million to accelerate deployment.

Led · Series A · Dec 2024

Biomemory develops DNA-based end-to-end storage solutions, including a recently launched DNA storage card and a planned data‑center appliance. The company uses proprietary synthetic-biology processes to produce long, bio-sourced, biocompatible DNA fragments stored as inert polymers for thousands of years without energy input. Biomemory says its technology offers ultra-high density, longevity, and improved sustainability versus traditional archival media. The company plans to complete first-generation appliance development, accelerate partnerships with industry and cloud providers, and recruit molecular biology and engineering talent. Biomemory aims to scale its molecular data storage to exabyte scale for data center use by 2030. Founded in 2021 as a spinoff of Sorbonne University and CNRS, the company is based in Paris and positions its technology as a complementary, low‑impact archival solution. Biomemory develops a petrol-free DNA synthesis and copy process and DNA data storage solutions that produce long, bio-sourced, biocompatible and bio-secure DNA fragments which can be stored as inert polymers for thousands of years without energy input. The company leverages synthetic biology mechanisms refined over billions of years to assemble DNA and aims to reduce the climate impact of data centers. Biomemory states it currently has the potential to reduce storage costs to $1 per megabyte and expects that further optimization and scaling could bring costs to $1 per terabyte, compared with a ten-year cost of $17 per terabyte for magnetic tape. To achieve this, the company plans to focus on miniaturization, automation and parallelization of an end-to-end integrated and continuous microfluidic DNA assembly device. Biomemory was founded in 2021 and is led by President Erfane Arwani. It has raised seed funding to support technology optimization.